HUP0101820A2 - Emberi táplálék veseelégtelenségben szenvedő betegek számára - Google Patents

Emberi táplálék veseelégtelenségben szenvedő betegek számára

Info

Publication number
HUP0101820A2
HUP0101820A2 HU0101820A HUP0101820A HUP0101820A2 HU P0101820 A2 HUP0101820 A2 HU P0101820A2 HU 0101820 A HU0101820 A HU 0101820A HU P0101820 A HUP0101820 A HU P0101820A HU P0101820 A2 HUP0101820 A2 HU P0101820A2
Authority
HU
Hungary
Prior art keywords
product
acid
citrates
arginine
citric acid
Prior art date
Application number
HU0101820A
Other languages
English (en)
Inventor
Carol Jo Lowry
Kathy Marie Sass
Original Assignee
Novartis Nutrition Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Nutrition Ag. filed Critical Novartis Nutrition Ag.
Publication of HUP0101820A2 publication Critical patent/HUP0101820A2/hu
Publication of HUP0101820A3 publication Critical patent/HUP0101820A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

A találmány szerint a vese glomeruláris funkciójában fontos szerepetjátszó L-arginint alkalmazzák egy kis viszkozitású, nagyenergiasűrűségű folyékony táplálék előállítására veseelégtelenségbenszenvedő betegek számára. Egy citromsavtól és citrátoktól mentes,szájon át fogyasztható termékben az arginin ízét tejsavval, almasavvalvagy adipinsavval nyomják el; egy mesterséges tápláláshoz alkalmazotttermékben a meghatározott arányban jelenlévő citromsav és citrátokszabályozzák a termék stabilitását. A termékben szabályozott a kalciumés foszfor egymáshoz viszonyított aránya, az energiatartalom-megoszlásés a víztartalom; a vitaminokat és ásványi anyagokat a készítmény ateljes tápérték eléréséhez szükséges mennyiségben tartalmazza. Ó
HU0101820A 1998-05-13 1999-05-11 Nutritional product for a person having renal failure HUP0101820A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/078,165 US6288116B1 (en) 1998-05-13 1998-05-13 Method of administration of a nutritional product to a person having renal failure
PCT/EP1999/003214 WO1999058001A1 (en) 1998-05-13 1999-05-11 Nutritional product for a person having renal failure

Publications (2)

Publication Number Publication Date
HUP0101820A2 true HUP0101820A2 (hu) 2001-10-28
HUP0101820A3 HUP0101820A3 (en) 2003-01-28

Family

ID=22142340

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101820A HUP0101820A3 (en) 1998-05-13 1999-05-11 Nutritional product for a person having renal failure

Country Status (21)

Country Link
US (2) US6288116B1 (hu)
EP (1) EP1077616B1 (hu)
JP (1) JP4846900B2 (hu)
CN (1) CN1117528C (hu)
AR (1) AR015291A1 (hu)
AT (1) ATE229758T1 (hu)
AU (1) AU742545B2 (hu)
BR (1) BR9911789A (hu)
CA (1) CA2331854C (hu)
CZ (1) CZ302085B6 (hu)
DE (1) DE69904589T2 (hu)
ES (1) ES2189427T3 (hu)
HU (1) HUP0101820A3 (hu)
ID (1) ID27268A (hu)
IL (1) IL139170A (hu)
MX (1) MXPA00011066A (hu)
PL (1) PL196939B1 (hu)
RU (1) RU2266020C2 (hu)
TW (1) TWI236347B (hu)
WO (1) WO1999058001A1 (hu)
ZA (2) ZA200005253B (hu)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
EP1372641A4 (en) * 2001-03-05 2004-08-25 Stephen P Ernest ENTERAL FORMULATION
US6605310B2 (en) * 2001-06-06 2003-08-12 Nestec S.A. Calorically dense liquid oral supplement
WO2003033020A1 (en) * 2001-10-17 2003-04-24 Ganado Research, L.L.C. Composition and method to treat post-illness wasting phenomenon
ES2355890T3 (es) 2002-04-05 2011-04-01 Societe des Produits Nestlé S.A. Composiciones y métodos para promocionar la asimilación de lípidos en los animales domésticos.
US20030194423A1 (en) * 2002-04-15 2003-10-16 Mars, Inc. Composition for enhancing nutritional content of food
US20040197401A1 (en) * 2002-06-14 2004-10-07 Calton Gary J Modifying undesirable tastes
JP2004097034A (ja) * 2002-09-05 2004-04-02 Howaizu:Kk Ｌ−アルギニン粉末およびこれを含有する食品
US20050064013A1 (en) * 2002-10-11 2005-03-24 Jeffrey Liebrech Ready to drink beverage composition having liquid form HGH pre-cursor and method of making same
KR100510987B1 (ko) * 2002-12-12 2005-08-31 박래옥 음료조성물
US20040137080A1 (en) * 2003-01-13 2004-07-15 Cremisi Henry D. Multivitamin regimen for renal patients
DE60321832D1 (de) * 2003-05-07 2008-08-07 Ciba Holding Inc Bleichzusammensetzung und bleichwaschmittelzusammensetzung
US7067156B1 (en) * 2003-11-10 2006-06-27 Vesselin Danailov Miladinov Dietary supplement for renal dialysis patients
EP1634599A1 (en) 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
US8647660B2 (en) * 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
AU2006236345B2 (en) * 2005-04-19 2011-03-31 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of kidney disease
GB0607402D0 (en) 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
US20080026105A1 (en) * 2006-07-28 2008-01-31 Bristol-Myers Squibb Company Nutritional formulations containing octenyl succinate anhydride-modified tapioca starch
WO2009057994A1 (en) * 2007-11-02 2009-05-07 N.V. Nutricia Unit dosage for brain health
US20100047363A1 (en) * 2008-11-07 2010-02-25 John Wigneswaran Nutritional supplement for patients with chronic kidney disease
PT2374452T (pt) 2008-12-05 2019-10-31 Ajinomoto Kk Composição de nutrientes
CN101849642B (zh) * 2010-05-25 2012-07-25 西安力邦临床营养有限公司 一种高能方便食品
CN105747218A (zh) 2010-06-28 2016-07-13 雀巢产品技术援助有限公司 低热量、高蛋白质营养组合物及其应用方法
MX2012015231A (es) 2010-06-28 2013-01-28 Nestec Sa Metodos para la administracion de formulaciones para alimentacion por sonda.
WO2013129912A1 (en) * 2012-02-28 2013-09-06 N.V. Nutricia Energy-rich liquid nutritional composition having improved organoleptic properties
AU2014238147B2 (en) 2013-03-15 2019-01-31 Mars, Incorporated Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting
ES2825064T3 (es) 2013-03-15 2021-05-14 Mars Inc Composición y método para prevenir, reducir, aliviar o tratar el vómito idiopático
MX357998B (es) * 2015-03-20 2018-07-11 Antonio Hernandez Miramontes Jorge Una mezcla de acidos carboxilicos, especificamente acido citrico, acido succinico, acido fumarico y acido malico para el tratamiento de pacientes con insuficiencia renal cronica, insuficiencia renal aguda, hepatopatias agudas o cronicas que cursen con hiperamonemia, enfermedades congenitas con alteraciones enzimaticas en el ciclo de la urea, asi como condiciones clínicas que cursen con balance nitrogenado negativo.
SG10201507786YA (en) * 2015-09-18 2017-04-27 Changi General Hospital Pte Ltd A food product and a method of preparing the same
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
TWI775921B (zh) 2017-08-14 2022-09-01 美商胺細拉健康公司 用於治療和高血氨症或肌肉耗損中之一者或兩者相關之肝疾病及失調之組合物及方法
US20200345056A1 (en) * 2018-01-26 2020-11-05 Abbott Laboratories Tube feeding composition and method for preparation thereof
MA52971A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
WO2021071375A1 (ru) * 2019-10-07 2021-04-15 Александр Иванович Леляк Функциональная питьевая вода
CN112690459B (zh) * 2020-12-23 2023-03-31 内蒙古蒙牛乳业（集团）股份有限公司 水解乳清蛋白、组合物及其临床应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957938A (en) 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease
DK0421309T4 (da) * 1989-10-02 2003-04-22 Associated British Foods Plc Proteinhydrolysater
US5239647A (en) * 1990-09-07 1993-08-24 International Business Machines Corporation Data storage hierarchy with shared storage level
US5108767A (en) 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
US5221668A (en) 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
CA2143420C (en) * 1992-12-23 1999-01-19 Phyllis J. B. Acosta Medical foods for the nutritional support of infant/toddler metabolic diseases
US5438042B1 (en) 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
GB9403935D0 (en) * 1994-03-01 1994-04-20 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5576287A (en) 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
US5776913A (en) * 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
AU1925697A (en) * 1996-03-12 1997-10-01 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US6096785A (en) * 1996-07-30 2000-08-01 Novartis Nutrition Ag Amino acid compositions and use thereof in treating renal dysfunction
US6013273A (en) * 1997-01-27 2000-01-11 Novartis Nutrition Ag Treatment of endotoxic shock
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure

Also Published As

Publication number Publication date
US6376544B2 (en) 2002-04-23
ATE229758T1 (de) 2003-01-15
US20010007878A1 (en) 2001-07-12
CZ20004194A3 (cs) 2001-03-14
WO1999058001A1 (en) 1999-11-18
CN1300191A (zh) 2001-06-20
CZ302085B6 (cs) 2010-10-06
ZA200006253B (en) 2002-03-27
HUP0101820A3 (en) 2003-01-28
CN1117528C (zh) 2003-08-13
DE69904589D1 (de) 2003-01-30
JP4846900B2 (ja) 2011-12-28
PL196939B1 (pl) 2008-02-29
AU4141399A (en) 1999-11-29
BR9911789A (pt) 2001-04-03
IL139170A (en) 2004-12-15
PL343686A1 (en) 2001-08-27
US6288116B1 (en) 2001-09-11
DE69904589T2 (de) 2003-09-25
ID27268A (id) 2001-03-22
JP2002514575A (ja) 2002-05-21
CA2331854A1 (en) 1999-11-18
AR015291A1 (es) 2001-04-18
RU2266020C2 (ru) 2005-12-20
EP1077616A1 (en) 2001-02-28
ES2189427T3 (es) 2003-07-01
ZA200005253B (en) 2002-03-27
CA2331854C (en) 2009-09-22
IL139170A0 (en) 2001-11-25
TWI236347B (en) 2005-07-21
AU742545B2 (en) 2002-01-03
MXPA00011066A (es) 2003-10-06
EP1077616B1 (en) 2002-12-18

Similar Documents

Publication Publication Date Title
HUP0101820A2 (hu) Emberi táplálék veseelégtelenségben szenvedő betegek számára
Huth et al. Major scientific advances with dairy foods in nutrition and health
Flodin The metabolic roles, pharmacology, and toxicology of lysine.
RU2000131188A (ru) Питательный продукт для человека, страдающего почечной недостаточностью
CA2371696A1 (en) Composition for an infant formula having a low threonine content
Jones et al. Oral essential aminoacid and ketoacid supplements in children with chronic renal failure
PT1638415E (pt) Fórmula para lactentes ou de transição
US4957938A (en) Nutritional formulation for the treatment of renal disease
FI972744A0 (fi) Aminohappokokoonpanoja ja niiden käyttö kliinisessä ravinnossa
US5411757A (en) Palatable balanced amino acid-modified diet
Zezulka et al. Nitrogen retention in men fed varying levels of amino acids from soy protein with or without added L-methionine
Liao et al. Homeostatic regulation of plasma amino acid concentrations
O’Brien et al. Nutritional aspects of cheese
JPS62270522A (ja) 尿毒症を治療するための栄養補強物
Rose The role of the amino acids in human nutrition
McDougall et al. Plant-based diets are not nutritionally deficient
DE50207740D1 (de) Verwendung von phosphatidylserin zur behandlung des aufmerksamkeits-defizit-syndroms (adhs)
Graber et al. Proline essentiality and weight gain
CA2704092A1 (en) Food material for inhibiting osteoclastogenesis
JPH02119761A (ja) 乳酸カルシウム含有飲料及び固形製剤
Boass et al. Enhanced nonsaturable calcium transport in the jejunum of rats during lactation, but not during pregnancy
Ohno et al. Effect of dietary lysine level on plasma free amino acids in adult cockerels
Ahassa et al. The Effect of Cow and Soy Milk Consumption on Calcium Levels of Wistar Rat Teeth
EP0377119A1 (en) Agent for reducing adverse effects of table salt
HK1025560A1 (en) Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: NESTEC S.A., CH

Free format text: FORMER OWNER(S): NOVARTIS NUTRITION AG., CH; NOVARTIS AG., CH

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished